BeOne Medicines AG
F:49BA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BeOne Medicines AG
F:49BA
|
CH |
|
F
|
Federal Home Loan Mortgage Corp
XMUN:FHL
|
US |
|
Elmera Group ASA
F:1ZK
|
NO |
|
Singapore Post Ltd
OTC:SPSTY
|
SG |
|
V
|
Valeo SE
F:VSA
|
FR |
|
Cuscal Ltd
F:Y49
|
AU |
|
C
|
China Conch Venture Holdings Ltd
OTC:CCVTF
|
CN |
|
S
|
Sumitomo Realty & Development Co Ltd
F:RL2
|
JP |
Wall St Price Targets
49BA Price Targets Summary
BeOne Medicines AG
According to Wall Street analysts, the average 1-year price target for 49BA is 440.5 EUR with a low forecast of 367.62 EUR and a high forecast of 567.89 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 49BA's stock price target?
Price Target
440.5
EUR
According to Wall Street analysts, the average 1-year price target for 49BA is 440.5 EUR with a low forecast of 367.62 EUR and a high forecast of 567.89 EUR.
What is the Revenue forecast for BeOne Medicines AG?
Projected CAGR
11%
Over the last 6 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for BeOne Medicines AG?
Projected CAGR
10%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 54%. The projected CAGR for the next 6 years is 10%.
What is the Operating Income forecast for BeOne Medicines AG?
Projected CAGR
33%
The compound annual growth rate for Operating Income over the next 8 years is 33%.
What is the Pre-Tax Income forecast for BeOne Medicines AG?
Projected CAGR
73%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 73%.
What is the Net Income forecast for BeOne Medicines AG?
Projected CAGR
45%
The compound annual growth rate for Net Income over the next 8 years is 45%.